or Try an Advanced Search...

    Treatment Of Breast Cancer Stocks List

    Symbol Grade Name % Change
    GTHX A G1 Therapeutics, Inc. 0.00
    PBYI C Puma Biotechnology Inc 2.11
    VSTM D Verastem, Inc. 3.69
    HOLX D Hologic, Inc. 0.87
    SLS D SELLAS Life Sciences Group, Inc. -1.61
    CHRS D Coherus BioSciences, Inc. 0.00
    ICAD D icad inc. -0.32
    BCTX D BriaCell Therapeutics Corp. 31.00
    ZNTL F Zentalis Pharmaceuticals, Inc. 1.60
    CLDX F Celldex Therapeutics, Inc. -0.68
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
    Related Stock Lists: Breast Cancer Cancer Biopharmaceutical Medicine Biotechnology Clinical Medicine Advanced Breast Cancer Oncology Ovarian Cancer Advanced Cancer Breast Imaging Cancer Research Cancer Screening Cancer Treatment Endometrial Cancer Epidermal Growth Factor Receptor Her2 Her2/Neu Imaging Immune System

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Breast Cancer stocks.

    Symbol Grade Name Weight
    EKG B First Trust Nasdaq Lux Digital Health Solutions ETF 3.76
    MDCP A VictoryShares THB Mid Cap ESG ETF 2.93
    IHI A iShares U.S. Medical Devices ETF 2.14
    MDEV D First Trust Indxx Medical Devices ETF 2.07
    USRD A Themes US R&D Champions ETF 1.94
    View all Treatment Of Breast Cancer ETFs...
    Compare ETFs
    Compare EKG to MDCP Compare MDCP to MDEV Compare MDEV to USRD

        Treatment Of Breast Cancer Stocks Recent News

        Date Stock Title
        Nov 21 PBYI PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer
        Nov 21 BCTX BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study
        Nov 21 PBYI Puma commences Phase II trial of alisertib for breast cancer treatment
        Nov 20 PBYI Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 17 ICAD Need To Know: Analysts Just Made A Substantial Cut To Their iCAD, Inc. (NASDAQ:ICAD) Estimates
        Nov 16 ICAD iCAD Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        Nov 16 SLS We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate
        Nov 15 HOLX Should You Retain Hologic Stock in Your Portfolio Now?
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
        Related Stock Lists: Breast Cancer Cancer Biopharmaceutical Medicine Biotechnology Clinical Medicine Advanced Breast Cancer Oncology Ovarian Cancer Advanced Cancer Breast Imaging Cancer Research Cancer Screening Cancer Treatment Endometrial Cancer Epidermal Growth Factor Receptor Her2 Her2/Neu Imaging Immune System
        Treatment Of Breast Cancer

        Treatment of breast cancer depends on the type and stage of the cancer, as well as the patient's age, overall health, and personal preferences. Treatment options may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, and/or immunotherapy.

        Browse All Tags